Discovery and development of USP30 inhibitors as disease-modifying therapy for parkinson's disease

Ended Project Grant Awarded Last action

Award ID
R43NS115255
Recipient
Awarding agency
Obligated
$251,987

Award facts

Assistance listing
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
Completion date
Place of performance
Cambridge, MA 02142, USA

Award details come from USAspending.gov.

Quick answers

Who received award R43NS115255?

R43NS115255 was awarded to Vincere Biosciences, Inc. by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on May 1, 2020.

How much is award R43NS115255 worth?

$251,987 has been obligated on R43NS115255.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award